The Mayo Clinic Center for Regenerative Medicine and National University Ireland Galway "have signed a formal memorandum of understanding to pave the way for joint clinical trials using regenerative therapies."

The NUI Galway Regenerative Medicine Institute and the Network of Excellence for Functional Biomaterials have long collaborated with Mayo and will now "focus on adult stem-cell therapy, gene therapy, biomaterials and biomedical engineering."

Student and staff exchange will also occur.

The goal is "more rapid introduction of new therapies for patients" based on Food and Drug Administration and European Medicines Agency efforts.

"There have been many developments in stem cell technologies over the years, and we are getting to the point of bringing this new knowledge and technology to the patients," said Dr. Anthony Windebank,Mayo deputy director for Discovery at the Mayo Clinic Center for Regenerative Medicine. "This is a unique collaboration which emphasizes the translation of laboratory discoveries into regenerative medicine therapies for patients."